polyclonal antisera Search Results


99
Eppendorf AG anti gal polyclonal antisera
Anti Gal Polyclonal Antisera, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti gal polyclonal antisera/product/Eppendorf AG
Average 99 stars, based on 1 article reviews
anti gal polyclonal antisera - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

91
Rockland Immunochemicals polyclonal antiserum
Polyclonal Antiserum, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal antiserum/product/Rockland Immunochemicals
Average 91 stars, based on 1 article reviews
polyclonal antiserum - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

90
Boehringer Mannheim polyclonal antisera r35
Polyclonal Antisera R35, supplied by Boehringer Mannheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal antisera r35/product/Boehringer Mannheim
Average 90 stars, based on 1 article reviews
polyclonal antisera r35 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Cocalico Inc rabbit polyclonal antisera rhsas2-4e7-h6
Rabbit Polyclonal Antisera Rhsas2 4e7 H6, supplied by Cocalico Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antisera rhsas2-4e7-h6/product/Cocalico Inc
Average 90 stars, based on 1 article reviews
rabbit polyclonal antisera rhsas2-4e7-h6 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Kunkel GmbH polyclonal rabbit antisera 6-10
Polyclonal Rabbit Antisera 6 10, supplied by Kunkel GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit antisera 6-10/product/Kunkel GmbH
Average 90 stars, based on 1 article reviews
polyclonal rabbit antisera 6-10 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Sanquin polyclonal rabbit antisera directed either against nder p 2 or nder p 1
Polyclonal Rabbit Antisera Directed Either Against Nder P 2 Or Nder P 1, supplied by Sanquin, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit antisera directed either against nder p 2 or nder p 1/product/Sanquin
Average 90 stars, based on 1 article reviews
polyclonal rabbit antisera directed either against nder p 2 or nder p 1 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Abmart Inc anti-pbr1 rabbit polyclonal antisera
Anti Pbr1 Rabbit Polyclonal Antisera, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-pbr1 rabbit polyclonal antisera/product/Abmart Inc
Average 90 stars, based on 1 article reviews
anti-pbr1 rabbit polyclonal antisera - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Autogen-Bioclear ltd polyclonal rabbit antimouse gr antisera
Polyclonal Rabbit Antimouse Gr Antisera, supplied by Autogen-Bioclear ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit antimouse gr antisera/product/Autogen-Bioclear ltd
Average 90 stars, based on 1 article reviews
polyclonal rabbit antimouse gr antisera - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Alpha Diagnostics polyclonal antisera
Polyclonal Antisera, supplied by Alpha Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal antisera/product/Alpha Diagnostics
Average 90 stars, based on 1 article reviews
polyclonal antisera - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Kaneka Corp polyclonal rabbit antisera against c-terminal peptide human lpcat1 cnsdagrkpvrkkld
Silencing of <t>LPCAT1</t> and LPCAT2 by siRNA leads to enlarged lipid droplets in A431 cells. A) A431 cells were either left untreated (untreated, wt), mock transfected (mock), transfected with control siRNA (eg5 as transfection control, leads to cell death, or scrambled#5 + #6 as non-targeting siRNAs) or the four possible combinations of two sequences each against LPCAT1 or LPCAT2 as indicated. After 48 h cells were lysed and subjected to SDS-PAGE/Western blotting for LPCAT1, LPCAT2 and glycerol-3-phosphate dehydrogenase (GAPDH, as a load control). B) Confocal images of controls and LPCAT1/LPCAT2 double-knock-downs as described in panel A . Nuclei (blue), LDs (green), scalebar = 10 μm. C) Confocal images as described in panel B were quantified with Image J for LD size distribution as described in . Data are mean LD size ± StdDev, calculated from >50 individual cells in 3 independent experiments. Significances relative to non-targeting siRNAs were calculated by unpaired two-sided T -test analysis (*** p ≤ 0.001, ** p ≤ 0.01, * p ≤ 0.05). D) Confocal image as described in panel B were quantified with ImageJ. Data show mean lipid droplet number per frame, corrected for variations in cell density, calculated from >50 individual cells in 3 independent experiments. Control: scrambled#5 + #6, LPCAT siRNA: average of all siRNA treatments. Significance was calculated by unpaired two-sided T -test analysis (*** p ≤ 0.001).
Polyclonal Rabbit Antisera Against C Terminal Peptide Human Lpcat1 Cnsdagrkpvrkkld, supplied by Kaneka Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit antisera against c-terminal peptide human lpcat1 cnsdagrkpvrkkld/product/Kaneka Corp
Average 90 stars, based on 1 article reviews
polyclonal rabbit antisera against c-terminal peptide human lpcat1 cnsdagrkpvrkkld - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Covance polyclonal bcar3 antisera
Silencing of <t>LPCAT1</t> and LPCAT2 by siRNA leads to enlarged lipid droplets in A431 cells. A) A431 cells were either left untreated (untreated, wt), mock transfected (mock), transfected with control siRNA (eg5 as transfection control, leads to cell death, or scrambled#5 + #6 as non-targeting siRNAs) or the four possible combinations of two sequences each against LPCAT1 or LPCAT2 as indicated. After 48 h cells were lysed and subjected to SDS-PAGE/Western blotting for LPCAT1, LPCAT2 and glycerol-3-phosphate dehydrogenase (GAPDH, as a load control). B) Confocal images of controls and LPCAT1/LPCAT2 double-knock-downs as described in panel A . Nuclei (blue), LDs (green), scalebar = 10 μm. C) Confocal images as described in panel B were quantified with Image J for LD size distribution as described in . Data are mean LD size ± StdDev, calculated from >50 individual cells in 3 independent experiments. Significances relative to non-targeting siRNAs were calculated by unpaired two-sided T -test analysis (*** p ≤ 0.001, ** p ≤ 0.01, * p ≤ 0.05). D) Confocal image as described in panel B were quantified with ImageJ. Data show mean lipid droplet number per frame, corrected for variations in cell density, calculated from >50 individual cells in 3 independent experiments. Control: scrambled#5 + #6, LPCAT siRNA: average of all siRNA treatments. Significance was calculated by unpaired two-sided T -test analysis (*** p ≤ 0.001).
Polyclonal Bcar3 Antisera, supplied by Covance, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal bcar3 antisera/product/Covance
Average 90 stars, based on 1 article reviews
polyclonal bcar3 antisera - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
ICN Pharmaceuticals polyclonal goat anti-mouse c3 antisera
Silencing of <t>LPCAT1</t> and LPCAT2 by siRNA leads to enlarged lipid droplets in A431 cells. A) A431 cells were either left untreated (untreated, wt), mock transfected (mock), transfected with control siRNA (eg5 as transfection control, leads to cell death, or scrambled#5 + #6 as non-targeting siRNAs) or the four possible combinations of two sequences each against LPCAT1 or LPCAT2 as indicated. After 48 h cells were lysed and subjected to SDS-PAGE/Western blotting for LPCAT1, LPCAT2 and glycerol-3-phosphate dehydrogenase (GAPDH, as a load control). B) Confocal images of controls and LPCAT1/LPCAT2 double-knock-downs as described in panel A . Nuclei (blue), LDs (green), scalebar = 10 μm. C) Confocal images as described in panel B were quantified with Image J for LD size distribution as described in . Data are mean LD size ± StdDev, calculated from >50 individual cells in 3 independent experiments. Significances relative to non-targeting siRNAs were calculated by unpaired two-sided T -test analysis (*** p ≤ 0.001, ** p ≤ 0.01, * p ≤ 0.05). D) Confocal image as described in panel B were quantified with ImageJ. Data show mean lipid droplet number per frame, corrected for variations in cell density, calculated from >50 individual cells in 3 independent experiments. Control: scrambled#5 + #6, LPCAT siRNA: average of all siRNA treatments. Significance was calculated by unpaired two-sided T -test analysis (*** p ≤ 0.001).
Polyclonal Goat Anti Mouse C3 Antisera, supplied by ICN Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal goat anti-mouse c3 antisera/product/ICN Pharmaceuticals
Average 90 stars, based on 1 article reviews
polyclonal goat anti-mouse c3 antisera - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Silencing of LPCAT1 and LPCAT2 by siRNA leads to enlarged lipid droplets in A431 cells. A) A431 cells were either left untreated (untreated, wt), mock transfected (mock), transfected with control siRNA (eg5 as transfection control, leads to cell death, or scrambled#5 + #6 as non-targeting siRNAs) or the four possible combinations of two sequences each against LPCAT1 or LPCAT2 as indicated. After 48 h cells were lysed and subjected to SDS-PAGE/Western blotting for LPCAT1, LPCAT2 and glycerol-3-phosphate dehydrogenase (GAPDH, as a load control). B) Confocal images of controls and LPCAT1/LPCAT2 double-knock-downs as described in panel A . Nuclei (blue), LDs (green), scalebar = 10 μm. C) Confocal images as described in panel B were quantified with Image J for LD size distribution as described in . Data are mean LD size ± StdDev, calculated from >50 individual cells in 3 independent experiments. Significances relative to non-targeting siRNAs were calculated by unpaired two-sided T -test analysis (*** p ≤ 0.001, ** p ≤ 0.01, * p ≤ 0.05). D) Confocal image as described in panel B were quantified with ImageJ. Data show mean lipid droplet number per frame, corrected for variations in cell density, calculated from >50 individual cells in 3 independent experiments. Control: scrambled#5 + #6, LPCAT siRNA: average of all siRNA treatments. Significance was calculated by unpaired two-sided T -test analysis (*** p ≤ 0.001).

Journal: BMC Cell Biology

Article Title: Two different pathways of phosphatidylcholine synthesis, the Kennedy Pathway and the Lands Cycle, differentially regulate cellular triacylglycerol storage

doi: 10.1186/s12860-014-0043-3

Figure Lengend Snippet: Silencing of LPCAT1 and LPCAT2 by siRNA leads to enlarged lipid droplets in A431 cells. A) A431 cells were either left untreated (untreated, wt), mock transfected (mock), transfected with control siRNA (eg5 as transfection control, leads to cell death, or scrambled#5 + #6 as non-targeting siRNAs) or the four possible combinations of two sequences each against LPCAT1 or LPCAT2 as indicated. After 48 h cells were lysed and subjected to SDS-PAGE/Western blotting for LPCAT1, LPCAT2 and glycerol-3-phosphate dehydrogenase (GAPDH, as a load control). B) Confocal images of controls and LPCAT1/LPCAT2 double-knock-downs as described in panel A . Nuclei (blue), LDs (green), scalebar = 10 μm. C) Confocal images as described in panel B were quantified with Image J for LD size distribution as described in . Data are mean LD size ± StdDev, calculated from >50 individual cells in 3 independent experiments. Significances relative to non-targeting siRNAs were calculated by unpaired two-sided T -test analysis (*** p ≤ 0.001, ** p ≤ 0.01, * p ≤ 0.05). D) Confocal image as described in panel B were quantified with ImageJ. Data show mean lipid droplet number per frame, corrected for variations in cell density, calculated from >50 individual cells in 3 independent experiments. Control: scrambled#5 + #6, LPCAT siRNA: average of all siRNA treatments. Significance was calculated by unpaired two-sided T -test analysis (*** p ≤ 0.001).

Article Snippet: Polyclonal rabbit antisera against the C-terminal peptide of human LPCAT1 CNSDAGRKPVRKKLD, conjugated to keyhole limpet hemocyanin, and against purified recombinant 6His-hLPCAT2 310-545 were raised by Eurogentec (Seraing, Belgium) and were affinity purified against the respective antigen.

Techniques: Transfection, SDS Page, Western Blot

Silencing of LPCAT1 by siRNA leads to enlarged lipid droplets and reduced lipoprotein secretion in HuH7 cells. A) HuH7 cells were either left untreated (untreated, wt), mock transfected (mock), transfected with control siRNA (scrambled#5 or scrambled#6 as non-targeting siRNAs) or the two different siRNA sequences against LPCAT1 as indicated. After 72 h cells were subjected to a LPCAT activity assay or Western blotting (WB) for LPCAT1 using GAPDH, as load control. B) Confocal images of controls and LPCAT1 knock-downs as described in panel A . Nuclei (blue), LDs (green), scale bar = 10 μm C + D) Confocal images as described in panel B were quantified for LD size distribution as described in . Data represented mean LD size ± StdDev, calculated from > 50 individual cells in 3 independent experiments. Significances were calculated by unpaired two-sided T -test analysis relative to non-targeting siRNA (scrambled#5) (*** p ≤ 0.001). For analysis of LD size distribution (panel D ), LDs were grouped into size classes, and the distribution displayed as percentage of total LDs per size class. Controls (black, light and dark grey and white), siRNAs against LPCAT1 (red, blue). E) Confocal images as described in panel B were quantified with Image J. Data show mean lipid droplet number per frame, corrected for variations in cell density, calculated from >50 individual cells in 3 independent experiments. Control: average of scrambled#5 and scrambled#6, LPCAT siRNA: average of both siRNA treatments. Significance was calculated by unpaired two-sided T -test analysis (*** p ≤ 0.001). F) HuH7 cells were transfected with non-targeting siRNA (control) or different siRNA sequences targeting LPCAT1 as indicated. ApoB secretion was measured by ELISA (dark grey, data represent mean ± StdDev, n = 4) or by Western blotting (light grey, data represent mean ± StdDev, n = 5). [3H]lipid secretion after labeling with 1 μCi [3H]oleate was calculated as % of total radioactivity recovered (supernatant + cells) and normalized to control. Data represent mean ± StdDev, n = 4. p-Values were obtained by unpaired T -test relative to the respective control (** p ≤ 0.01, * p ≤ 0.05).

Journal: BMC Cell Biology

Article Title: Two different pathways of phosphatidylcholine synthesis, the Kennedy Pathway and the Lands Cycle, differentially regulate cellular triacylglycerol storage

doi: 10.1186/s12860-014-0043-3

Figure Lengend Snippet: Silencing of LPCAT1 by siRNA leads to enlarged lipid droplets and reduced lipoprotein secretion in HuH7 cells. A) HuH7 cells were either left untreated (untreated, wt), mock transfected (mock), transfected with control siRNA (scrambled#5 or scrambled#6 as non-targeting siRNAs) or the two different siRNA sequences against LPCAT1 as indicated. After 72 h cells were subjected to a LPCAT activity assay or Western blotting (WB) for LPCAT1 using GAPDH, as load control. B) Confocal images of controls and LPCAT1 knock-downs as described in panel A . Nuclei (blue), LDs (green), scale bar = 10 μm C + D) Confocal images as described in panel B were quantified for LD size distribution as described in . Data represented mean LD size ± StdDev, calculated from > 50 individual cells in 3 independent experiments. Significances were calculated by unpaired two-sided T -test analysis relative to non-targeting siRNA (scrambled#5) (*** p ≤ 0.001). For analysis of LD size distribution (panel D ), LDs were grouped into size classes, and the distribution displayed as percentage of total LDs per size class. Controls (black, light and dark grey and white), siRNAs against LPCAT1 (red, blue). E) Confocal images as described in panel B were quantified with Image J. Data show mean lipid droplet number per frame, corrected for variations in cell density, calculated from >50 individual cells in 3 independent experiments. Control: average of scrambled#5 and scrambled#6, LPCAT siRNA: average of both siRNA treatments. Significance was calculated by unpaired two-sided T -test analysis (*** p ≤ 0.001). F) HuH7 cells were transfected with non-targeting siRNA (control) or different siRNA sequences targeting LPCAT1 as indicated. ApoB secretion was measured by ELISA (dark grey, data represent mean ± StdDev, n = 4) or by Western blotting (light grey, data represent mean ± StdDev, n = 5). [3H]lipid secretion after labeling with 1 μCi [3H]oleate was calculated as % of total radioactivity recovered (supernatant + cells) and normalized to control. Data represent mean ± StdDev, n = 4. p-Values were obtained by unpaired T -test relative to the respective control (** p ≤ 0.01, * p ≤ 0.05).

Article Snippet: Polyclonal rabbit antisera against the C-terminal peptide of human LPCAT1 CNSDAGRKPVRKKLD, conjugated to keyhole limpet hemocyanin, and against purified recombinant 6His-hLPCAT2 310-545 were raised by Eurogentec (Seraing, Belgium) and were affinity purified against the respective antigen.

Techniques: Transfection, Activity Assay, Western Blot, Enzyme-linked Immunosorbent Assay, Labeling, Radioactivity

Increase in LD size upon LPCAT1/2 knock-down is independent of neutral lipid synthesis and accumulation. A) A431 cells were transfected with siRNA as described in Figure A. Seventy hours after siRNA transfection growth medium was exchanged to medium containing 10% delipidated FCS and 50 μM alkyne-oleate. After two hours cells were washed and lipids extracted. Extracts were subjected to quantitative click-analysis for the ratio of incorporation of alkyne fatty acid into TAG and PC. Data are mean ± StdDev, n = 3. Significances were calculated by unpaired two-sided T -test analysis relative to non-targeting siRNA (scrambled#5 + #6) and were found to be insignificant. B) A431 cells were transfected as described in Figure A. After 48 h, total lipid extracts were analyzed by mass spectrometry in duplicate samples, and species abundances were normalized to the corresponding internal standard. The molar contents of each species of the same class were summed up and normalized to the total content of all detectable lipids. C) HuH7 cells were transfected with siRNA as described in Figure A. Seventy hours after siRNA transfection as indicated, growth medium was exchanged to medium containing 10% delipidated FCS and 50 μM alkyne-oleate. After two hours, cells were washed, lipids extracted and extracts were subjected to quantitative click-analysis as in panel A . Data are mean ± StdDev, n = 3. Significances were calculated compared to non-targeting siRNAs (scrambled#5) and were found to be insignificant. D) HuH7 cells were transfected as described in Figure A. After 72 h, total lipid extracts were analyzed by mass spectrometry in duplicate samples. Species abundances were normalized as described for panel B .

Journal: BMC Cell Biology

Article Title: Two different pathways of phosphatidylcholine synthesis, the Kennedy Pathway and the Lands Cycle, differentially regulate cellular triacylglycerol storage

doi: 10.1186/s12860-014-0043-3

Figure Lengend Snippet: Increase in LD size upon LPCAT1/2 knock-down is independent of neutral lipid synthesis and accumulation. A) A431 cells were transfected with siRNA as described in Figure A. Seventy hours after siRNA transfection growth medium was exchanged to medium containing 10% delipidated FCS and 50 μM alkyne-oleate. After two hours cells were washed and lipids extracted. Extracts were subjected to quantitative click-analysis for the ratio of incorporation of alkyne fatty acid into TAG and PC. Data are mean ± StdDev, n = 3. Significances were calculated by unpaired two-sided T -test analysis relative to non-targeting siRNA (scrambled#5 + #6) and were found to be insignificant. B) A431 cells were transfected as described in Figure A. After 48 h, total lipid extracts were analyzed by mass spectrometry in duplicate samples, and species abundances were normalized to the corresponding internal standard. The molar contents of each species of the same class were summed up and normalized to the total content of all detectable lipids. C) HuH7 cells were transfected with siRNA as described in Figure A. Seventy hours after siRNA transfection as indicated, growth medium was exchanged to medium containing 10% delipidated FCS and 50 μM alkyne-oleate. After two hours, cells were washed, lipids extracted and extracts were subjected to quantitative click-analysis as in panel A . Data are mean ± StdDev, n = 3. Significances were calculated compared to non-targeting siRNAs (scrambled#5) and were found to be insignificant. D) HuH7 cells were transfected as described in Figure A. After 72 h, total lipid extracts were analyzed by mass spectrometry in duplicate samples. Species abundances were normalized as described for panel B .

Article Snippet: Polyclonal rabbit antisera against the C-terminal peptide of human LPCAT1 CNSDAGRKPVRKKLD, conjugated to keyhole limpet hemocyanin, and against purified recombinant 6His-hLPCAT2 310-545 were raised by Eurogentec (Seraing, Belgium) and were affinity purified against the respective antigen.

Techniques: Transfection, Mass Spectrometry

The LPCAT1/2 fly ortholog CG32699 resembles human LPCAT1 and 2. A) Drosophila melanogaster S2 Schneider cells were transfected with GFP-CG32699, which is the fly ortholog of mammalian LPCAT1 and LPCAT2. The growth medium was supplemented with 100 μM oleate. In the merged image, LDs are shown in red and CG32699 in green. Lower panels show a higher magnification of the central region of the pictures in the upper panels. Scalebar = 10 μm. Note the colocalization of GFP and LD540 signals. Resolution is limited due to the small size and round shape of S2 cells. B) Female virgin flies of a tubulin-Gal4 containing fly strain were crossed with male flies of three different CG32699-specific RNAi containing fly strains. L3 larvae were selected, fat bodies were isolated and representative DIC images of those fat bodies are shown for wildtype (wt), white mutant (white) and the three RNAi strains 32382, 32924 and 104570. The amount of CG32699 mRNA was measured by quantitative PCR. Scale bar = 10 μm. C + D) Bright field images as shown in panel B were quantified with ImageJ. Mean lipid droplet number per frame and mean lipid droplet size is presented for 3 frames per condition of 4 different experiments. significances were calculated by unpaired T -test analysis (*** p ≤ 0.001, ** p ≤0.01) compared to control. E) Female virgin flies of a tubulin-Gal4 containing fly strain were crossed with male flies of 3 different CG32699-specific RNAi containing fly strains or white mutant (white). From each cross three L3 larvae were selected and subjected to a LPCAT activity assay. Data were analyzed with Gel Pro Analyzer. Standard deviations and significances were calculated from three experiments by unpaired T -test analysis (** p ≤ 0.01, * p ≤0.05) compared to control (white).

Journal: BMC Cell Biology

Article Title: Two different pathways of phosphatidylcholine synthesis, the Kennedy Pathway and the Lands Cycle, differentially regulate cellular triacylglycerol storage

doi: 10.1186/s12860-014-0043-3

Figure Lengend Snippet: The LPCAT1/2 fly ortholog CG32699 resembles human LPCAT1 and 2. A) Drosophila melanogaster S2 Schneider cells were transfected with GFP-CG32699, which is the fly ortholog of mammalian LPCAT1 and LPCAT2. The growth medium was supplemented with 100 μM oleate. In the merged image, LDs are shown in red and CG32699 in green. Lower panels show a higher magnification of the central region of the pictures in the upper panels. Scalebar = 10 μm. Note the colocalization of GFP and LD540 signals. Resolution is limited due to the small size and round shape of S2 cells. B) Female virgin flies of a tubulin-Gal4 containing fly strain were crossed with male flies of three different CG32699-specific RNAi containing fly strains. L3 larvae were selected, fat bodies were isolated and representative DIC images of those fat bodies are shown for wildtype (wt), white mutant (white) and the three RNAi strains 32382, 32924 and 104570. The amount of CG32699 mRNA was measured by quantitative PCR. Scale bar = 10 μm. C + D) Bright field images as shown in panel B were quantified with ImageJ. Mean lipid droplet number per frame and mean lipid droplet size is presented for 3 frames per condition of 4 different experiments. significances were calculated by unpaired T -test analysis (*** p ≤ 0.001, ** p ≤0.01) compared to control. E) Female virgin flies of a tubulin-Gal4 containing fly strain were crossed with male flies of 3 different CG32699-specific RNAi containing fly strains or white mutant (white). From each cross three L3 larvae were selected and subjected to a LPCAT activity assay. Data were analyzed with Gel Pro Analyzer. Standard deviations and significances were calculated from three experiments by unpaired T -test analysis (** p ≤ 0.01, * p ≤0.05) compared to control (white).

Article Snippet: Polyclonal rabbit antisera against the C-terminal peptide of human LPCAT1 CNSDAGRKPVRKKLD, conjugated to keyhole limpet hemocyanin, and against purified recombinant 6His-hLPCAT2 310-545 were raised by Eurogentec (Seraing, Belgium) and were affinity purified against the respective antigen.

Techniques: Transfection, Isolation, Mutagenesis, Real-time Polymerase Chain Reaction, Activity Assay